Lukas Hainz

Imagine a world where life-saving cancer treatments no longer require weeks of waiting for cell processing or come with a price tag in the hundreds of thousands of dollars, but instead can be administered in days at a fraction of the cost. This is the promise of in vivo CAR cell therapy, an

In a world where the global population is aging at an unprecedented rate, with projections estimating that nearly a quarter of humanity will be over 65 within the next two decades, the urgency to address age-related diseases like Alzheimer’s has never been more critical, posing immense challenges

Across the globe, millions of people lack access to timely and accurate disease diagnosis due to the high costs and invasive nature of traditional medical testing, often leaving critical conditions undetected until it’s too late, a challenge that has spurred remarkable innovation. A pioneering

In a world where breast cancer claims countless lives each year, a staggering statistic emerges: over 70% of cases are estrogen receptor-positive (ER+), making them particularly challenging to treat due to their ability to adapt and resist therapies. Imagine a microscopic battlefield within the

In a world where humanity faces pressing challenges like sustainable energy and life-threatening diseases, the emergence of artificial intelligence as a collaborative partner in scientific discovery offers a beacon of hope. Imagine a future where complex experiments that once took decades are

In a city where healthcare access remains a pressing concern for many, Jacksonville's innovative telehealth program, Healthlink Jax, has emerged as both a beacon of hope and a source of contention among residents and officials. Designed to alleviate the burden on emergency rooms by redirecting

In an era where social bonds are increasingly strained by distance and life changes, loneliness and depression among older adults have emerged as significant public health concerns, affecting millions globally and creating a pressing need for innovative solutions. Factors such as the loss of loved

In a groundbreaking stride for neuroscience, the Allen Institute for Brain Science has unveiled the Brain Knowledge Platform (BKP), a pioneering digital database that promises to redefine how the global scientific community approaches brain research. Loaded with data from over 34 million brain

In a landscape where patients with relapsed or refractory T-cell lymphoma face a grim prognosis, often with a median survival of just six months under current treatments, a new ray of hope has emerged through innovative research. This aggressive cancer, marked by limited therapeutic options, has

The landscape of rare disease drug development is littered with clinical failures. For every success, countless promising compounds fail to demonstrate efficacy in late-stage trials, often due to the inherent challenges of studying small, heterogeneous patient populations. BridgeBio Pharma’s recent